Kirk Schultz
Overview
Explore the profile of Kirk Schultz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
1808
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Peters C, Dalle J, Locatelli F, Poetschger U, Sedlacek P, Buechner J, et al.
J Clin Oncol
. 2020 Dec;
39(4):295-307.
PMID: 33332189
Purpose: Total body irradiation (TBI) before allogeneic hematopoietic stem cell transplantation (HSCT) in pediatric patients with acute lymphoblastic leukemia (ALL) is efficacious, but long-term side effects are concerning. We investigated...
2.
Bejanyan N, Kim S, Hebert K, Kekre N, Abdel-Azim H, Ahmed I, et al.
Blood Adv
. 2019 Oct;
3(20):3123-3131.
PMID: 31648332
Allogeneic bone marrow transplantation (BMT) is curative therapy for the treatment of patients with severe aplastic anemia (SAA). However, several conditioning regimens can be used for BMT. We evaluated transplant...
3.
Lazaryan A, Wang T, Spellman S, Wang H, Pidala J, Nishihori T, et al.
Haematologica
. 2016 Jun;
101(10):1267-1274.
PMID: 27247320
The diversity of the human leukocyte antigen (HLA) class I and II alleles can be simplified by consolidating them into fewer supertypes based on functional or predicted structural similarities in...
4.
Lankester A, Locatelli F, Bader P, Rettinger E, Egeler M, Katewa S, et al.
Biol Blood Marrow Transplant
. 2014 Jul;
21(3):402-11.
PMID: 25064748
Although allogeneic hematopoietic stem cell transplantation (HSCT) is a curative approach for many pediatric patients with hematologic malignancies and some nonmalignant disorders, some critical obstacles remain to be overcome, including...
5.
Fernandez-Vina M, Wang T, Lee S, Haagenson M, Aljurf M, Askar M, et al.
Blood
. 2014 Jan;
123(8):1270-8.
PMID: 24408320
In subjects mismatched in the HLA alleles C*03:03/C*03:04 no allogeneic cytotoxic T-lymphocyte responses are detected in vitro. Hematopoietic stem cell transplantation (HSCT) with unrelated donors (UDs) showed no association between...
6.
Ferrara J, Anasetti C, Stadtmauer E, Antin J, Wingard J, Lee S, et al.
Biol Blood Marrow Transplant
. 2007 Oct;
13(11):1268-85.
PMID: 17950914
Outcomes of hematopoietic cell transplantation are steadily improving. New techniques have reduced transplant toxicities, and there are new sources of hematopoietic stem cells from unrelated donors. In June 2007 the...
7.
Prendiville J, Rogers M, Kan A, de Castro F, Wong M, Junker A, et al.
Pediatr Dermatol
. 2007 Apr;
24(2):101-7.
PMID: 17461801
A novel pigmented dermatosis was observed in four unrelated boys, three of whom had insulin-dependent diabetes. Three patients were the offspring of consanguineous parents. All four boys had pigmented hypertrichotic...
8.
Couriel D, Carpenter P, Cutler C, Bolanos-Meade J, Treister N, Gea-Banacloche J, et al.
Biol Blood Marrow Transplant
. 2006 Mar;
12(4):375-96.
PMID: 16545722
The Ancillary Therapy and Supportive Care Working Group had 3 goals: (1) to establish guidelines for ancillary therapy and supportive care in chronic graft-versus-host disease (GVHD), including treatment for symptoms...
9.
Shulman H, Kleiner D, Lee S, Morton T, Pavletic S, Farmer E, et al.
Biol Blood Marrow Transplant
. 2006 Jan;
12(1):31-47.
PMID: 16399567
This consensus document provides an update for pathologists and clinicians about the interpretation of biopsy results and use of this information in the management of hematopoietic cell transplantation patients. Optimal...
10.
Filipovich A, Weisdorf D, Pavletic S, Socie G, Wingard J, Lee S, et al.
Biol Blood Marrow Transplant
. 2005 Dec;
11(12):945-56.
PMID: 16338616
This consensus document is intended to serve 3 functions. First, it standardizes the criteria for diagnosis of chronic graft-versus-host disease (GVHD). Second, it proposes a new clinical scoring system (0-3)...